Contineum Therapeutics (NASDAQ: CTNM) is owned by 0.00% institutional shareholders, 9.96% Contineum Therapeutics insiders, and 90.04% retail investors. Johnson Johnson is the largest individual Contineum Therapeutics shareholder, owning 1.98M shares representing 7.32% of the company. Johnson Johnson's Contineum Therapeutics shares are currently valued at $31.67M.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.